Surgical and Non-Surgical Convergence in Hepatocellular Carcinoma

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".

Deadline for manuscript submissions: 31 July 2026 | Viewed by 23

Special Issue Editor


E-Mail Website
Guest Editor
Hepatobiliary and Liver Transplantation Unit, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, 35128 Padova, Italy
Interests: hepatocellular carcinoma; multiparametric therapeutic hierarchy; conversion therapy; liver transplantation
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Hepatocellular carcinoma (HCC) remains a significant global health burden, with 866,136 new cases and a mortality-to-incidence ratio of 0.86 reported in 2022. Primarily caused by liver cirrhosis, HCC is increasingly linked to non-viral causes, particularly metabolic dysfunction-associated steatotic liver disease and alcohol-related liver disease. While liver transplantation and resection continue to be the main curative options, the past decade has seen notable advances in non-surgical treatments—including ablation, transarterial therapies, and systemic treatments—that have transformed the therapeutic landscape.

Instead of being seen as alternative or competing options, these treatments are increasingly regarded within integrative frameworks, such as the Multiparametric and Converse Therapeutic Hierarchies, where combined and sequential strategies reveal curative possibilities that were once considered unreachable.

This special issue invites original research, high-quality reviews, and translational perspectives that challenge traditional staging and treatment paradigms while exploring the integration of surgical and non-surgical approaches in HCC. Special focus will be on studies addressing downstaging, curative conversion, therapeutic stage migration, and multiparametric/multidisciplinary decision-making approaches.

By bringing together work at the forefront of integrated HCC management, this issue strives to define a future where therapeutic boundaries are flexible, personalised for patients, and focused on maximising survival and potential for cure.

Dr. Alessandro Vitale
Guest Editor

Marco Brolese
Ilaria Govoni
Virginia Padoan
Guest Editor Assistants

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • hepatocellular carcinoma
  • conversion therapy
  • HCC treatment boundaries
  • surgical–non-surgical convergence
  • multidisciplinary HCC management

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop